No Data
No Data
Dean Schauer Appointed Chairman of the Board of Confluent Medical Technologies
Scotiabank Maintains Confluent(CFLT.US) With Hold Rating, Cuts Target Price to $25
Scotiabank analyst Nick Altmann maintains $Confluent(CFLT.US)$ with a hold rating, and adjusts the target price from $28 to $25.According to TipRanks data, the analyst has a success rate of 34.4%
Express News | Confluent Inc - Acquisition Not Expected to Impact 2024 Financial Results
Express News | Confluent Acquires Warpstream to Advance Next-Gen Byoc Data Streaming
Confluent Acquires Streaming Data Startup WarpStream
This Analyst With 83% Accuracy Rate Sees More Than 36% Upside In Alphabet - Here Are 5 Stock Picks For August From Wall Street's Most Accurate Analysts